Morphological spectrum of immune check‐point inhibitor therapy‐associated gastritis von Johncilla, Melanie, Grover, Shilpa, Zhang, Xuchen, Jain, Dhanpat, Srivastava, Amitabh

Volltext

Gastroparesis Following Immune Checkpoint Inhibitor Therapy: A Case Series von Atieh, Jessica, Sack, Jordan, Thomas, Richard, Rahma, Osama E., Camilleri, Michael, Grover, Shilpa

Volltext

Correction to: Gastroparesis Following Immune Checkpoint Inhibitor Therapy: A Case Series von Atieh, Jessica, Sack, Jordan, Thomas, Richard, Rahma, Osama E., Camilleri, Michael, Grover, Shilpa

Volltext

Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals von Ukaegbu, Chinedu, Levi, Zohar, Fehlmann, Tara D., Uno, Hajime, Chittenden, Anu, Inra, Jennifer A., Grover, Shilpa, Kastrinos, Fay, Syngal, Sapna, Yurgelun, Matthew B.

Volltext

Esophagitis dissecans superficialis with immune checkpoint inhibitor therapy von Coolidge, Alexis, Rodriguez, Nicolette Juliana, Pomerantz, Mark, Grover, Shilpa

Volltext

Checkpoint inhibitor induced esophagitis with documented resolution on infliximab von Chen, Frank W., Liu, Anne F., Srivastava, Amitabh, Buchbinder, Elizabeth, Grover, Shilpa

Volltext

Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients von Grover, Shilpa, Stoffel, Elena M., Bussone, Laoti, Tschoegl, Elizabeth, Syngal, Sapna

Volltext

Lymphocytic colitis–like pattern of mucosal injury and the challenges in diagnosing cancer immunotherapy‐related toxicity von Grover, Shilpa, Srivastava, Amitabh

Volltext

Hereditary Pancreatic Cancer von Grover, Shilpa, Syngal, Sapna

Volltext

Gastrointestinal and Hepatic Toxicities of Checkpoint Inhibitors: Algorithms for Management von Grover, Shilpa, Rahma, Osama E, Hashemi, Nikroo, Lim, Ramona M

Volltext

Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) service von Abu-Shawer, Osama, Singh, Prabhsimranjot, Yenulevich, Eric, Brito, Amanda, Ni, Jian, Abdulnour, Raja-Elie E., Grover, Shilpa, Manos, Michael, Bowling, Peter, LeBoeuf, Nicole R., Ott, Patrick, Hodi, F. Stephen, Jacobson, Joseph, Rahma, Osama

Volltext

Su1275 IMMUNE CHECKPOINT INHIBITOR ESOPHAGITIS: TREATMENT OUTCOMES AND COMPLICATIONS von Mumtaz, Afeerah, Townsend, Matthew J., Sack, Jordan S., Grover, Shilpa

Volltext

481 Impact of COVID-19 on Cancer Patients Receiving Immune Checkpoint Inhibitors von Tyan, Kevin, Bui, Ai-Tram, Giobbie-Hurder, Anita, Klein, Isaac, Manos, Michael, Zubiri, Leyre, Reynolds, Kerry, Grover, Shilpa, Weinhouse, Gerald, Ott, Patrick, LeBoeuf, Nicole, Rahma, Osama

Volltext

Impact of COVID-19 on Patients with Cancer Receiving Immune Checkpoint Inhibitors von Bui, Ai-Tram N, Tyan, Kevin, Giobbie-Hurder, Anita, Klein, Isaac A, Manos, Michael P, Zubiri, Leyre, Reynolds, Kerry, Grover, Shilpa, Weinhouse, Gerald L, Ott, Patrick A, LeBoeuf, Nicole R, Rahma, Osama

Volltext

Su1249: CANCER OUTCOMES IN PATIENTS TREATED WITH BIOLOGICS FOR THE TREATMENT OF STEROID-REFRACTORY IMMUNE CHECKPOINT INHIBITOR COLITIS von Gupta, Sanchit, Raj, Dhanya, Kogan, Lawrence, Grover, Shilpa

Volltext

Su1246: PREDICTORS OF NEED FOR BIOLOGIC THERAPY IN IMMUNE CHECKPOINT INHIBITOR COLITIS von Gupta, Sanchit, Raj, Dhanya, Kogan, Lawrence, Grover, Shilpa

Volltext

Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors von Townsend, Matthew J., Benque, Isaac J., Li, Michael, Grover, Shilpa

Volltext

Colorectal Cancer Risk Perception on the Basis of Genetic Test Results in Individuals at Risk for Lynch Syndrome von GROVER, Shilpa, STOFFEL, Elena M, CHUNG, Daniel C, SYNGAL, Sapna, MERCADO, Rowena C, FORD, Beth M, KOHLMAN, Wendy K, SHANNON, Kristen M, CONRAD, Peggy G, BLANCO, Amie M, TERDIMAN, Jonathan P, GRUBER, Stephen B

Volltext

Outcomes after resumption of immune checkpoint inhibitor therapy after high‐grade immune‐mediated hepatitis von Li, Michael, Sack, Jordan S., Rahma, Osama E., Hodi, F. Stephen, Zucker, Stephen D., Grover, Shilpa

Volltext

Tu1172: CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF IMMUNE CHECKPOINT INHIBITOR GASTRITIS IN PATIENTS WITH CANCER von Haryal, Aneesha, Baskaran, Vinitha, Srivoleti, Padmavathi, Sack, Jordan S., Grover, Shilpa

Volltext